The analysis of literature data indicates a significant role of impaired functional activity of GSK-3β in the pathogenesis of schizophrenia [33] and affective disorders [34] and the possibility of using the kinase as a molecular target for the development of therapeutic strategies. Here, GSK3B is linked to schizophrenia.